Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sites.
about
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragmentA Strategy for Modulation of Enzymes in the Ubiquitin SystemSelection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.Bioinformatics prediction of overlapping frameshifted translation products in mammalian transcripts.Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.Thrombopoietin from beginning to end.Identification of the residues in the extracellular domain of thrombopoietin receptor involved in the binding of thrombopoietin and a nuclear distribution protein (human NUDC).Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.Quantitative evaluation of the chicken lysozyme epitope in the HyHEL-10 Fab complex: free energies and kinetics.Identification of functionally important residues of human thrombopoietin.Mutational analysis of the major coat protein of M13 identifies residues that control protein display.Human thrombopoietin structure-function relationships: identification of functionally important residues.Monoclonal antibody epitope mapping describes tailspike beta-helix folding and aggregation intermediates.
P2860
Q27643107-D83892F0-F521-4B49-91AD-3C62A0F3D632Q27675727-E7F5EAB7-E7C0-42E6-8C7B-FCB15BAF0214Q32065974-FBBFB404-86CF-4165-8EDC-B4BBDEF322FBQ33322942-E928F1A3-18D9-40AA-A2B7-F25403A65ABAQ33410668-FC6CCC63-99A9-454C-8D5D-3AD750C88AA7Q33413170-65E1121E-9025-4438-861D-4ECB34CB178FQ34074510-2980D1AE-34DF-49C8-9F99-3C86CF0AE5BCQ35007278-B3E47078-92C9-411D-80BC-8DF96C56B0A1Q35728878-5E9F7BB6-EA1D-49A7-8F64-2178A5576C5BQ36281312-AC978724-CDAF-422B-8CA6-60BF458C9653Q41067735-D8A07F13-884E-4604-B3DE-7BE5B5ABAEE2Q41733808-731D0196-D9A6-49A4-A69D-47D5F903599EQ42004864-E630225B-5B53-494A-B05E-EE9868EEA679Q50091591-E0C067B8-3E8C-45E5-B928-83484CD808D0
P2860
Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sites.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@en
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@nl
type
label
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@en
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@nl
prefLabel
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@en
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@nl
P2093
P2860
P356
P1476
Mutational analysis of thrombo ...... d neutralizing antibody sites.
@en
P2093
P2860
P304
20595-20602
P356
10.1074/JBC.272.33.20595
P407
P577
1997-08-01T00:00:00Z